Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects

Acta Cardiologica

Volumn 54, Issue 2, 1999, Pages 77-81

  Erem, Cihangir ^a   Deǧer, Orhan ^b   Bostan, Mehmet ^b   Örem, Asim ^b   Sönmez, Mehmet ^b   Ulusoy, Şükrü ^b   Telatar, Münir ^b  

^a Tip Fakültesi   (Turkey)

^b NONE

Author keywords

Hyperthyroidism; Hypothyroidism; Lipoprotein (a)

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; THYROID HORMONE; THYROXINE;

ADULT; ARTICLE; CATABOLISM; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; THYROID DISEASE; THYROXINE BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; LIPOPROTEIN(A); MALE; MIDDLE AGED; REFERENCE VALUES; THYROID FUNCTION TESTS; THYROXINE;

EID: 0344603594     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Staels B, Van Tol A, Chan A, Will H, Verhoeven G, Auwerx J. Alterations in thyroid status modulate apolipoproteins, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology 1990; 127: 1144-1152.
2. Nishitani H, Okamura K, Inoue K, Morotomi Y, Fujishima M. Serum lipid levels in thyroid dysfunction with special reference to transient elevation during treatment in hyperthyroid Graves disease. Horm Metab Res 1990; 22: 490-493.
3. Brindley DN, Salter AM. Hormonal regulation of the hepatic low density lipoproteins. Prog Lipid Res 1991; 30: 349-360.
4. Staub J-J, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, Burckhardt D, Girard J, Weintraub BD. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992; 92: 631-642.
5. Agdeppa D, Macaron C, Mallik T, Schnuda ND. Plasma high density lipoprotein in thyroid disease. J Clin Endocrinol Metab 1979; 49: 726-729.
6. Klausen IC, Nielsen FE, Hegedüs L, Gerdes LU, Charles P, Faergeman O. Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein (a). Metabolism 1992; 41: 911-914.
7. De Bruin TWA, Van Barlingen H, Van Line-Sibenius Trip M, Van Vuuest, Van Vries A-RR, Akveld MJ, Erkelens DW. Lipoprotein (a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects. J Clin Endocrinol Metab 1993; 76: 121-127.
8. Berg K. Genetics of atherogenic lipoprotein (a) and its relation to other atherosclerotic risk factors. Ann Intern Med 1991; 15: 209-218.
9. Trieu FN, Zionchek TF, Lawn RM, McConathy WJ. Interaction of apolipoprotein (a) with apolipoprotein B containing lipoproteins. J Biol Chem 1991; 5480-5485.
10. Krempler F, Kostner GM, Bolzano K. Turnover of lipoprotein (a) in man. J Clin Invest 1980; 65: 1483-1490.
11. Maartmann-Moe K, Berg K. Lp(a) lipoproteins enter cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor. Clin Genetics 1981; 20: 352-362.
12. Utermann G. The mysteries of lipoprotein (a). Science 1989; 246: 904-910.
13. Dahlen G, Ericson C, Berk K. In vitro studies of the interaction of isolated Lp(a) lipoprotein and other serum lipoproteins with glycosaminoglycans. Clin Genet 1978; 14: 36-42.
14. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle-aged men. Br Med J 1990; 301: 1248-1251.
15. Armstrong VW, Crener P, Eberle E, Marke A, Schulze F, Wieland H, Kreuzer H, Seidel D. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 1986; 62: 249-257.
16. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U. Detection and quantification of lipoprotein (a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989; 9: 579-592.
17. Bastenie PA, Vanhaelst L, Neve P. Coronary artery disease in hypothyroidism: observations in preclinical myxoedema. Lancet 1967; 2: 1221-1222.
18. Becker C. Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev 1985; 6: 432-440.
19. Arem A, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Arch Intern Med 1990; 150: 2097-2100.
20. Kuusi T, Taskinen M-R, Nikkila EA. Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. J Clin Endocrinol Metab 1988; 66: 51-56.
21. Abrams JJ, Grundy SM, Ginsberg H. Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man. J Lipid Res 1981a; 22: 307-322.
22. Muls E, Rosseneu M, Blaton V, Lesaffre E, Lamberigts G, De Moor P. Serum lipids and apolipoprotein A-I, A-II, and B in primary hypothyroidism before and during treatment. Eur J Clin Invest 1984; 14: 12-15.
23. Kostner G, Grillhofer HK. Lipoprotein (a) mediates high affinity low density lipoprotein association to receptor negative fibroblasts. Proc Natl Acad Sci USA 1991; 266: 21287-21292.
24. Bihara-Varga M, Gruber E, Rotheneder M, Zechner R, Kostner GM. Interaction of lipoprotein (a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 1988; 8: 851-857.
25. Dahlen G, Guyton JR, Attar M, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758-765.
26. Zioncheck TF, Powell LM, Rice GC, Eaton DL, Lawn RM. Interaction of recombinant apolipoprotein (a) and lipoprotein (a) with macrophages. J Clin Invest 1991; 87: 767-771.
27. Smith TJ, Bahn RS, Gorman CA. Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 1989; 10: 366-391.
28. Thompson GR, Soutar AK, Spengel FA, Jadhav A, Gavigan SJ, Myant NB. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci USA 1981; 78: 2591-2595.
29. 131I-low density lipoprotein in hypothyroidism and thyrotoxicosis. Clin Sci 1965; 29: 217-238.
30. Davidson NO, Carlos RC, Lukaszewicz AM. Apolipoprotein B mRNA editing is modulated by thyroid hormone analogs but not growth hormone administration in the rat. Mol Endocrinol 1990; 4: 779-785.
31. Abrarns JJ, Grundy SM. Cholesterol metabolism in hypothyroidism and hyperthyroidism in man. J Lipid Res 1981b; 22: 323-338.
32. Engler H, Riesen F. Effect of thyroid function on concentrations of lipoprotein (a). Clin Chem 1993; 39: 2466-2469.
33. Miura S, Iitaka M, Yoshimura H, Kitahama S, Fukasawa N, Kawakami Y, Sakurai S, Urabe M, Sakatsume Y, Ito K, Ishii J. Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy. Internal Medicine 1994; 33: 413-417.
34. O'Brien T, Dinneen SF, O'Brien PC, Palumbo JP. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 1993; 68: 860-866.
35. Lithell H, Boberg J, Hellsing K, Ljunghall S, Lundqvist G, Vessby B, Wide L. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy. Eur J Clin Invest 1981; 11: 3-10.
36. Caron P, Calazel C, Parra HJ, Hoff M, Louvet JP. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol 1990; 33: 519-523.
37. Raziel A, Rosenzweig B, Botvinic V, Beigel I, Landau B, Blum I. The influence of thyroid function on serum lipid profile. Atherosclerosis 1982; 41: 321-326.
38. Aviram M, Luboshitzky R, Brook JG. Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy. Clin Biochem 1982; 15: 62-66.